logo

AKBA

Akebia Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.58 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is AKBA a Buy, Sell, or Hold?
  • Based on a composite score of 4.58/10, we rate AKBA as a Netural. Our analysis breaks down into 2.33/10 for Fundamentals, 5.96/10 for Technicals, and 5.01/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is AKBA fundamentally strong?
What is the current technical signals for AKBA?
What is the analyst consensus for AKBA?